検索結果

Milestones in Our History | About Senju | SENJU Pharmaceutical

1947 Apri Hiroshi Tsuzuki (CEO) established the company in Tennoji-ku, Osaka with start-up capital of 195,000 yen. July Injection Product for Neutropenia, "PANILTIN", sales launched 1949 Feb...

CEO Message | About Senju | SENJU Pharmaceutical

the happiness of everyone associated with Senju and continue to be a “Good Company” as a management principle. To do this, we engage in “if I were you” - the company concept that helps us see the pers...

Our Initiatives for Society/Environment | About Senju | SENJU Pharmaceutical

to society through the cause of the idea to serve the health of people since our formation, through providing the pharmaceutical products. As better corporate citizens, we promote the environmental me...

2301 B2301 RTH258B2302 B2302 52 6 mg 2.7% 10/368 1.1% 4/368 RTH258D2301 D2301 96 3 6 mg 5.5% 19/347 PRP 1.2% 4/342 1 MedDRA/J ver. 20.14 2 MedDRA/J ver. 23.1 3 MedDRA/J ver. 27.0 1. 2. Endophthalmiti...

Clinical Trial Summaries | Research & Development | SENJU Pharmaceutica

t of Clinical Trial Summaries ※Listed in order of date of first publication Medical Condition Phase Project Code Country Recruitment Status Access to Trial ID Allergic Conjunctivitis 3 SJP-0049 Japan ...